Ebola Outbreak in DRC Escalates, Urgent Community Response Urged DATELINE: Kampala, Uganda – August 18, 2026 LEAD: The Democratic Republic of the Congo (DRC) is addressing the fastest-growing Ebola outbreak in its history, prompting international health organizations to call for an urgent community-led response to contain the spread of the deadly virus. NUT GRAF: As of August 16, 2026, the DRC has reported 4,966 confirmed cases, 1,059 recoveries, and 2,327 deaths, with a fatality rate of 46. 86%.
The Africa Centres for Disease Control and Prevention (Africa CDC) and the World Health Organization (WHO) have emphasized the need for a scaled-up community-led Ebola response in the DRC, highlighting the importance of early detection, rapid contact tracing, and trusted community engagement.
The current Ebola outbreak in the DRC began on May 14, 2026, in the Ituri Province. This is the 17th Ebola outbreak in the country since the disease was first identified in 1976.
The Bundibugyo species of Ebola, which has no vaccine or specific treatment, is complicating response efforts.
The outbreak is also occurring in a challenging context, including a humanitarian crisis, remote and densely populated areas, insecurity, and high population and trade movements.
The WHO has been scaling up support to the governments of the DRC and Uganda, including strengthening surveillance, contact tracing, clinical preparedness, and management, delivery of supplies, and community engagement.
The Africa CDC and WHO have highlighted the importance of early detection, rapid contact tracing, coordinated national action, trusted community engagement, and strong cross — border surveillance in containing the outbreak.
The Coalition for Epidemic Preparedness Innovations (CEPI) has fast-tracked three investigational vaccines targeting the Bundibugyo ebolavirus. These candidates, developed by IAVI, Moderna, and the University of Oxford, will be manufactured at the Serum Institute of India (SII).
Clinical trials for the first ever Bundibugyo species — specific candidate vaccine began in the UK on July 24, 2026, with a second starting in Canada this week.
Despite ongoing efforts, there are still no proven safe and efficacious treatment, preventive, or vaccination options for the Bundibugyo species of the Ebola virus.
The WHO convened several of its expert and advisory groups to assess potential vaccines and therapeutics for both prevention and treatment of Bundibugyo virus disease (BVD).
The Africa CDC and WHO have called for an urgent scale — up of the community-led Ebola response in the DRC, with stronger early detection, contact follow-up, access to care, support for frontline health workers, and faster delivery of resources to affected communities.
The call followed a joint high — level mission to Uganda and DRC on August 4 and 5, which drew lessons from Uganda’s successful containment of local transmission and assessed operational challenges in Bunia. KICKER: The DRC’s ongoing Ebola outbreak underscores the critical need for coordinated international efforts to combat emerging infectious diseases.
As the situation evolves, the world watches closely to see how the DRC and its partners can contain the outbreak and prevent further loss of life.
*Additional reporting by ImNews | Sources consulted: 5*
—
This original article was produced by the ImNews editorial team
Source: reliefweb
Source: Emergency Telecommunications Cluster
